Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERα transgenic mice

Abstract

We identified a somatic mutation in estrogen receptor-α (ERα) in breast cancer causing a lysine to arginine transition (K303R) resulting in hypersensitivity to estrogen, altered associations with coactivators and corepressors and altered posttranslational modifications of ERα. We have developed a transgenic mouse expressing the K303R mutant ERα under control of the mouse mammary tumor virus (MMTV) promoter. At 4 months of age, K303R ERα transgenic animals demonstrate precocious alveolar budding compared with wild-type ERα transgenic mice or nontransgenic littermates. Despite these morphologic differences, K303R ERα transgenic mice displayed no differences in levels of ERα, progesterone receptor or proliferation at this time-point. Pregnancy or chronic estrogen plus progesterone exposure in K303R ERα transgenic mice also resulted in significantly more alveolar budding, increased β-casein production and dilated ducts when compared with nontransgenic littermates. To examine the effects of mutant expression on tumorigenesis, mutant ERα mice were crossed with FVB-MMTVneu mice and significantly delayed time to neu-mediated tumorigenesis in bigenic animals. In contrast, mutant expression did not affect carcinogen-induced tumorigenesis. Collectively, these data demonstrate that aberrant estrogenic signaling through the K303R ERα mutation may lead to precocious alveolar budding in virgin mice, and to an expedited maturation and differentiation phenotype in the mammary glands of hormonally stimulated animals.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Bershtein LM, Alimova IN, Tsyrlina EV, Anisimov VN . (2003). Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bull Exp Biol Med 135: 580–581.

    Article  CAS  PubMed  Google Scholar 

  • Bocchinfuso WP, Korach KS . (1997). Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2: 323–334.

    Article  CAS  PubMed  Google Scholar 

  • Borras M, Hardy L, Lempereur F, el Khissiin AH, Legros N, Gol-Winkler R et al. (1994). Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol 48: 325–336.

    Article  CAS  PubMed  Google Scholar 

  • Conway K, Parrish E, Edmiston SN, Tolbert D, Tse CK, Geradts J et al. (2005). The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study. Breast Cancer Res 7: R871–R880.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cui Y, Niu A, Pestell R, Kumar R, Curran EM, Liu Y et al. (2006). Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 20: 2020–2035.

    Article  CAS  PubMed  Google Scholar 

  • Cui Y, Zhang M, Pestell R, Curran EM, Welshons WV, Fuqua SA . (2004). Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity. Cancer Res 64: 9199–9208.

    Article  CAS  PubMed  Google Scholar 

  • Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C et al. (2005). Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 117: 988–991.

    Article  CAS  PubMed  Google Scholar 

  • Davies MP, O'Neill PA, Innes H, Sibson DR . (2005). Hypersensitive K303R oestrogen receptor-alpha variant not found in invasive carcinomas. Breast Cancer Res 7: R113–R118.

    Article  CAS  PubMed  Google Scholar 

  • Durban EM, Medina D, Butel JS . (1985). Comparative analysis of casein synthesis during mammary cell differentiation in collagen and mammary gland development in vivo. Dev Biol 109: 288–298.

    Article  CAS  PubMed  Google Scholar 

  • Frech MS, Halama ED, Tilli MT, Singh B, Gunther EJ, Chodosh LA et al. (2005). Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res 65: 681–685.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fuqua SA, Wiltschke C, Zhang QX, Borg A, Castles CG, Friedrichs WE et al. (2000). A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 60: 4026–4029.

    CAS  PubMed  Google Scholar 

  • Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ . (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578–10582.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S . (1999). Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96: 2520–2525.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Herynk MH, Fuqua SA . (2004). Estrogen receptor mutations in human disease. Endocr Rev 25: 869–898.

    Article  CAS  PubMed  Google Scholar 

  • Herynk MH, Parra I, Cui Y, Beyer A, Wu MF, Hilsenbeck SG et al. (2007). Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer. Clin Cancer Res 13: 3235–3243.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ip MM, Asch BB . (2000). Methods in mammary gland biology and breast cancer research. Kluwer Academic/Plenum Publishers: New York, xvi, 329 p., [4] leaves of col. platespp.

    Book  Google Scholar 

  • Jin Z, MacDonald RS . (2002). Soy isoflavones increase latency of spontaneous mammary tumors in mice. J Nutr 132: 3186–3190.

    Article  CAS  PubMed  Google Scholar 

  • Lavrovsky Y, Song CS, Chatterjee B, Roy AK . (1998). A rapid and reliable PCR-based assay for gene transmission and sex determination in newborn transgenic mice. Transgenic Res 7: 319–320.

    Article  CAS  PubMed  Google Scholar 

  • Medina D . (1974). Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice. J Natl Cancer Inst 53: 213–221.

    Article  CAS  PubMed  Google Scholar 

  • Medina D . (2004). Breast cancer: the protective effect of pregnancy. Clin Cancer Res 10: 380S–384S.

    Article  CAS  PubMed  Google Scholar 

  • Mishra SK, Mazumdar A, Vadlamudi RK, Li F, Wang RA, Yu W et al. (2003). MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J Biol Chem 278: 19209–19219.

    Article  CAS  PubMed  Google Scholar 

  • Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D . (2007). Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res 9: R12.

    Article  PubMed  PubMed Central  Google Scholar 

  • Richert MM, Schwertfeger KL, Ryder JW, Anderson SM . (2000). An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 5: 227–241.

    Article  CAS  PubMed  Google Scholar 

  • Russo J, Russo IH . (2004). Development of the human breast. Maturitas 49: 2–15.

    Article  CAS  PubMed  Google Scholar 

  • Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L . (2005). Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol Endocrinol 19: 2671–2684.

    Article  CAS  PubMed  Google Scholar 

  • Tekmal RR, Nair HB, Perla RP, Kirma N . (2007). HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis. J Steroid Biochem Mol Biol 106: 111–118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tilli MT, Frech MS, Steed ME, Hruska KS, Johnson MD, Flaws JA et al. (2003). Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma. Am J Pathol 163: 1713–1719.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tokunaga E, Kimura Y, Maehara Y . (2004). No hypersensitive estrogen receptor-alpha mutation (K303R) in Japanese breast carcinomas. Breast Cancer Res Treat 84: 289–292.

    Article  CAS  PubMed  Google Scholar 

  • Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C et al. (2001). Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 276: 18375–18383.

    Article  CAS  PubMed  Google Scholar 

  • Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N et al. (2003). Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res 63: 2425–2433.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Gary Chamness for editorial assistance and Ms Robin Sample for administrative assistance. This work was supported by NIH/NCI CA72038 to SAWF, and by DAMD17-03-1-0417 to MHH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S A W Fuqua.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herynk, M., Lewis, M., Hopp, T. et al. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERα transgenic mice. Oncogene 28, 3177–3187 (2009). https://doi.org/10.1038/onc.2009.174

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2009.174

Keywords

This article is cited by

Search

Quick links